Genmab A/S Financial Statements
NASDAQ: GMABHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Genmab A/S revenue and earnings
In fiscal 2025, Genmab A/S generated $3.72 billion in revenue, up 19.2% from fiscal 2024, its 2nd consecutive year of revenue growth. Net income was $963.0 million (-15.0% year over year), for a net margin of 25.9% versus a median of 31.4% in the prior 2 years. Gross margin was 93.6% (down from 95.4%) and operating margin 28.6%.
Diluted earnings per share came in at $15.37, down from $17.53. Over the last 2 fiscal years, GMAB's revenue has grown at a 24.8% compound annual rate.
Summary generated from market data by MetaCap's automated system. Methodology
Genmab A/S income statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 |
|---|---|---|---|
| Revenue | 3.72B | 3.12B | 2.39B |
| Revenue growth (YoY) | +19.19% | +30.59% | — |
| Cost of Revenue | 238.00M | 143.00M | 33.00M |
| Gross Profit | 3.48B | 2.98B | 2.36B |
| Operating Expenses | 2.65B | 2.15B | 1.62B |
| Research & Development | 1.61B | 1.41B | 1.11B |
| Selling, General & Admin | 626.00M | 549.00M | 478.00M |
| Operating Income | 1.06B | 972.00M | 772.00M |
| Interest Expense | 269.00M | 291.00M | 254.00M |
| Pretax Income | 1.20B | 1.33B | 817.00M |
| Income Tax | 241.00M | 193.00M | 186.00M |
| Net Income | 963.00M | 1.13B | 631.00M |
| Net Income growth (YoY) | -15.00% | +79.56% | — |
| EPS (Basic) | 15.50 | 17.66 | 9.67 |
| EPS (Diluted) | 15.37 | 17.53 | 9.58 |
| Shares Outstanding (Basic) | 64.72M | 66.14M | 66.02M |
| Shares Outstanding (Diluted) | 62.69M | 64.66M | 65.90M |
| Gross Margin | 93.60% | 95.42% | 98.62% |
| Operating Margin | 28.63% | 31.14% | 32.30% |
| Net Margin | 25.89% | 36.30% | 26.40% |
This table shows 3 annual periods of Genmab A/S's income statement, from FY 2025 back to FY 2023, across 18 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow GMAB's reporting calendar. What is a income statement?